TY - JOUR
T1 - Laboratory and Pharmaceutical Data Associated With Hospital Readmission in Persons With Diabetic Foot Ulcers
AU - Myers, Alyson K.
AU - Dawkins, Makeda
AU - Baskaran, Inthuja
AU - Izard, Stephanie
AU - Zhang, Meng
AU - Bissoonauth, Aditya A.
AU - Kaplan, Sally
AU - Rao, Amit
AU - Elzanaty, Mohammad
AU - Oropallo, Alisha
N1 - Publisher Copyright:
© The Author(s) 2021.
PY - 2021/11/19
Y1 - 2021/11/19
N2 - Purpose: Diabetic foot ulcers (DFUs) are a leading cause of lower extremity amputations among persons with diabetes (PWD) and a common cause of hospitalizations. This study identified demographic characteristics, lab values, and comorbidities associated with 30-day and 90-day hospital readmission in persons with DFU. Methods: A retrospective chart review at our institution examined 397 patients with type 2 diabetes admitted with DFU between January 2014 and December 2018. Variables were analyzed using descriptive statistics, t-tests, and logistic regressions. Results: None of the studied demographic, laboratory (including Hemoglobin A1c) or comorbid diseases were associated with 30-day readmission in persons with DFU. Risk factors for 90-day readmission included discharge location to home with health care (OR: 2.62, 95% CI: 1.39, 4.95), anticoagulant use (OR: 2.36, 95% CI: 1.27, 4.39), and SQ insulin use (OR: 2.08, 95% CI: 1.20, 3.61). Conclusions: None of the variables examined were associated with 30-day readmission; however, potential predictors for 90-day readmission included anticoagulation or insulin use and discharge home with healthcare services. Future studies should devise interventions to improve transition of care in patients with DFU to further assess the role of medications and home health care as a potential predictor of 90-day hospital readmission.
AB - Purpose: Diabetic foot ulcers (DFUs) are a leading cause of lower extremity amputations among persons with diabetes (PWD) and a common cause of hospitalizations. This study identified demographic characteristics, lab values, and comorbidities associated with 30-day and 90-day hospital readmission in persons with DFU. Methods: A retrospective chart review at our institution examined 397 patients with type 2 diabetes admitted with DFU between January 2014 and December 2018. Variables were analyzed using descriptive statistics, t-tests, and logistic regressions. Results: None of the studied demographic, laboratory (including Hemoglobin A1c) or comorbid diseases were associated with 30-day readmission in persons with DFU. Risk factors for 90-day readmission included discharge location to home with health care (OR: 2.62, 95% CI: 1.39, 4.95), anticoagulant use (OR: 2.36, 95% CI: 1.27, 4.39), and SQ insulin use (OR: 2.08, 95% CI: 1.20, 3.61). Conclusions: None of the variables examined were associated with 30-day readmission; however, potential predictors for 90-day readmission included anticoagulation or insulin use and discharge home with healthcare services. Future studies should devise interventions to improve transition of care in patients with DFU to further assess the role of medications and home health care as a potential predictor of 90-day hospital readmission.
KW - diabetic foot ulcer
KW - hemoglobin A1c
KW - readmissions
KW - type 2 diabetes
KW - wound care
UR - http://www.scopus.com/inward/record.url?scp=85120496438&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120496438&partnerID=8YFLogxK
U2 - 10.1177/00469580211060779
DO - 10.1177/00469580211060779
M3 - Article
C2 - 34842491
AN - SCOPUS:85120496438
SN - 0046-9580
VL - 58
JO - Inquiry (United States)
JF - Inquiry (United States)
ER -
